Cell Expansion Market Size to Reach USD 40.1 billion, Advancing at a CAGR of 12.1% by 2034: Exclusive Report by Transparency Market Research, Inc.
17 sept. 2024 06h50 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The global cell expansion market (세포 확장 시장) is estimated to flourish at a CAGR of 12.1%...
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
16 sept. 2024 16h26 HE
|
DSS, Inc.
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the...
Global Live Cell Imaging Market Report 2024-2029: Growing Adoption of High-Content Screening Techniques in Drug Discovery and Increasing Demand for Improved Understanding of Cellular Processes
16 sept. 2024 06h05 HE
|
Research and Markets
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Live Cell Imaging Global Market Report 2024-2029" report has been added to ResearchAndMarkets.com's offering. The global market for live cell...
Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging
15 sept. 2024 06h05 HE
|
Precede Biosciences, Inc.
Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 medicines in development Quantitative PSMA-PET...
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
15 sept. 2024 03h00 HE
|
MacroGenics, Inc.
Encouraging antitumor activity demonstrated with vobra duo as measured by 6-month landmark rPFS rate and ORRPatients remained on vobra duo through a median of 6 doses (ranging up to 12), representing...
MetasTx Welcomes Esteemed Cancer Scientist Dr. Jonathan Chernoff to the Board of Managers
13 sept. 2024 07h13 HE
|
MetasTx LLC
Dr. Chernoff’s decision to join the Board of Managers reflects his strong belief in MetasTx’s science and strategic direction.
SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference
13 sept. 2024 07h00 HE
|
SAB Biotherapeutics, Inc.
MIAMI, Sept. 13, 2024 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...
Harvey Homan to Highlight MetasTx’s Game-Changing Approach to Cancer Treatment at PA Life Science Futures
12 sept. 2024 06h58 HE
|
MetasTx LLC
MetasTx aims to revolutionize cancer treatment by targeting p21-activated kinase (PAK-1), a critical driver of metastasis in solid tumors.
Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut
11 sept. 2024 07h30 HE
|
Aurora Spine Corporation
CARLSBAD, CA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that...
MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare Conference
10 sept. 2024 16h30 HE
|
MannKind
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled...